MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Parkinson`s disease future prediction

    V. Raju, A. Dabbeta (Hyderabad, India)

  • Parkinson’s Disease and Cancer: A Meta-Analysis of Prevalence, Risk, and Specific Associations with Brain and Skin Cancers

    H. Khelifa, A. R. Al-Ihribat, H. Smeda, A. Hendawy, A. Abunamoos (Oran, Algeria)

  • Parkinson’s Disease and Movement Disorders Mortality in Tunisia: Insights from the National Information System on Causes-of-Death (2020-2021)

    M. Zribi, N. Zoghlami, S. Ben Maryem, M. Bennour, H. Aounallah-Skhiri (Tunis, Tunisia)

  • Parkinson’s Disease Diagnosed in a Patient with Anti-Musk Positive Myasthenia Gravis: Coincidence? – Case Report and Literature Review

    J. Sánchez León, T. Luise Denicol, C. Matté Dagostini, R. de Castro, A. Hilbig, A. Hoppe, C. Mello Rieder (Porto Alegre, Brazil)

  • Parkinson’s Disease Epidemiology and Treatment Characteristics in Australia

    M. Lubomski, A. Evans, R. Mackinnon, R. Rossiter, M. Falster, M. Kouhkamari, T. Suresh, A. Mikolaizak, J. Waern (St Leonards, Australia)

  • Parkinson’s disease GWAS-linked SNCA carriers show slower non-motor and cognitive progression

    DX. Deng, LT. Tan, TEK. Tan (singapore, Singapore)

  • Parkinson’s Disease: Increased Presence of Neuropsychiatric Symptoms and Non-Motor Issues Drive Higher Medication Use and Costs

    S. Horn, E. Vaou, A. Parab, S. Wang, X. Pan, C. Yan, M. Shah, J. Jimenez-Shahed (San Antonio, USA)

  • Parkinson’s Disease (PD) and Type II Diabetes (T2DM): Risk and Progression

    S. Goldman, F. Weaver, L. Cao, B. Gonzalez, S. Jugnundan, K. Stroupe, K. Colletta, E. Brown, C. Tanner (San Francisco, USA)

  • Parkinson’s disease (PD) associated with the E46K mutation in the SNCA gene, twenty years after

    B. Tijero Merino, MA. Acera Gil, I. Gabilondo, T. Fernandez Valle, M. Ruiz Lopez, R. Sanchez Pernaute, A. Murueta-Goyena, I. Diez, C. Juanes, R. Del Pino, N. Ayo-Mentxakatorre, JC. Gomez-Esteban (Barakaldo, Spain)

  • Parkinson’s Disease and Type 2 Diabetes Severity: a Case-control Biomarker Study

    B. Huxford, A. Zirra, E. Camboe, K. Dey, D. Gallagher, C. Budu, C. Simonet, T. Boyle, R. Dobson, A. Noyce (London, United Kingdom)

  • « Previous Page
  • 1
  • …
  • 119
  • 120
  • 121
  • 122
  • 123
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley